TITLE

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

PUB. DATE
January 2011
SOURCE
BMC Psychiatry;2011, Vol. 11 Issue 1, p145
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a research which examines the comparative efficacy of olanzapine, quetiapine, risperidone, and ziprasidone as anti-depressive drugs. It is reported that, the researchers used several methods including, Calgary Depression Scale for Schizophrenia (CDSS) for conducting the research. According to the research, there exists no substantial differences in the comparative efficacy of the drugs.
ACCESSION #
66584350

 

Related Articles

  • Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. Kalsekar, Iftekhar; Wagner, Jan-Samuel; DiBonaventura, Marco; Bates, Jay; Forbes, Robert; Hebden, Tony // Health & Quality of Life Outcomes;2012, Vol. 10 Issue 1, p81 

    Background: Use of atypical antipsychotics (AA) in combination with an antidepressant is recommended as an augmentation strategy for patients with depression. However, there is a paucity of data comparing aripiprazole and other AAs in terms of patient reported outcomes. Therefore, the objective...

  • Independent Nurse: Journals Watch - Newer antipsychotics do not reduce the risk of falls.  // GP: General Practitioner;9/16/2005, p73 

    The article reports that American researchers monitored over 2,000 patients and found the increased risk of falls associated with typical antipsychotics was 35 percent compared with 32 percent for risperidone and 74 percent for olanzapine. Those taking antidepressants were at a 45 percent...

  • Olanzapine/ziprasidone.  // Reactions Weekly;6/18/2011, Issue 1356, p27 

    The article describes the case of a 51-year-old woman with a severe depressive episode who gained weight during treatment with olanzapine and developed pruritus while taking ziprasidone.

  • Risperidone/ziprasidone.  // Reactions Weekly;7/21/2012, Issue 1411, p39 

    The article presents a case study of a 26-year-old female patient who developed worsening spasticity while receiving risperidone and ziprasidone.

  • Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics. Grover, Sandeep; Dutt, Alakananda; Chakrabarty, Kaustav; Kumar, Vineet // Industrial Psychiatry Journal;Jan-Jun2012, Vol. 21 Issue 1, p69 

    Non-catatonic mutism in schizophrenia has been described less frequently in literature. We describe the case of a young male who presented with non-catatonic mutism, secondary to fi rst rank symptoms, which was refractory to adequate antipsychotic trials (quetiapine, risperidone, aripiprazole,...

  • Olanzapine/sulpiride/valproate.  // Reactions Weekly;Nov2015, Vol. 1578 Issue 1, p227 

    The article describes a case report of a 25-year-old woman who experienced weight gain and metabolic syndrome during a cross-switch of treatment from olanzapine, valproate and sulpiride to ziprasidone.

  • Atypical Antipsychotic Drugs and Ethanol Withdrawal Syndrome: A Review. Uzbay, Tayfun I. // Alcohol & Alcoholism;Jan/Feb2012, Vol. 47 Issue 1, p33 

    Aims: Alcoholism and psychosis are known to have common neurochemical substrates. The aim of this review is to assess the reports involved in the effects of some atypical antipsychotic agents on the signs of ethanol withdrawal syndrome (EWS) in rats. Thus, both effectiveness of these drugs in...

  • Leki przeciwpsychotyczne w praktyce lekarza psychiatry. Leczenie pacjentów z rozpoznaniem schizofrenii lekoopornej. Meder, Joanna; Tyszkowska, Magdalena; Jarema, Marek; Araszkiewicz, Aleksander; Szafrański, Tomasz // Psychiatria Polska;2008, Vol. 42 Issue 6, p859 

    Aim. The aim of this paper is to present and to discuss the results of an investigation conducted among Polish psychiatrists in 2007, especially its part relating to the practice of therapeutic patterns in refractory schizophrenia. Method. Structured individual interviews were conducted from 100...

  • A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report. Arcari, Gail T.; Mendes, Asante K.; Sothern, Robert B. // Innovations in Clinical Neuroscience;Sep2012, Vol. 9 Issue 9, p21 

    Antipsychotic drug therapy, e.g., risperidone, can be associated with endocrine abnormalities, including an increase in serum prolactin level (sPrl) due to a drug-induced benign pituitary tumor (prolactinoma). A few case reports have noted a resolution of hyperprolactinemia and prolactinoma...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics